Ghana has built a reputation for timely diagnosis. But the numbers reveal a paradox: patients are diagnosed quickly, yet most arrive too late. The gap between those two facts is where lives are lost.
The Paradox: Fast Diagnosis, Late Presentation
Ghana performs well on one measure of breast cancer care. At Komfo Anokye Teaching Hospital (KATH), the country’s second-largest tertiary facility, every patient with histologically confirmed breast cancer received their diagnosis within 31 days of first presentation. Approximately 63% had core biopsies performed on the day of initial presentation, and 95% had their biopsy within 21 days. This meets the Global Breast Cancer Initiative (GBCI) target of confirming diagnosis within 60 days.
Â
But here is the problem. Only 10.3% of patients undergoing staging were diagnosed with early breast cancer (stage I or II). Half were diagnosed at stage III, and 39.3% at stage IV. The GBCI target is at least 60% early-stage diagnosis.
📢 GET A DETAILED ARTICLES + JOBS
Join ASJ's WhatsApp Channel and never miss a post or opportunity.
The system diagnoses quickly. But patients arrive late.
The Human Cost of Late Presentation
The survival gap is stark. A 2026 meta-analysis synthesizing data from 2,114 patients across major referral centers in Ghana found a pooled median overall survival of 4.4 years and an estimated 5-year survival rate of 46.5%. The mean age at diagnosis was 47.3 years, with most patients presenting with stage III disease (47.2%).
The Breast Society of Ghana has estimated that about 2,000 women die from breast cancer each year, with 60–70% of cases diagnosed at advanced stages.
For context, survival rates in high-income settings for early-stage disease exceed 90%. The difference is not biology. It is timing.
Why Women Present Late
The reasons are well-documented and deeply rooted in social, cultural, and economic realities.
The Traditional Medicine Pathway
A 2025 study at KATH examined patient factors associated with late-stage diagnosis. Using traditional medicine before seeking care at the cancer hospital was the only significant patient factor associated with late-stage breast cancer, after adjusting for age, marital status, health insurance, and education. The odds were substantial: patients who used traditional medicine had 4.14 times higher odds of late-stage presentation.
The study’s authors noted that while Ghana has taken steps to educate traditional healers to refer patients early, “efforts are still needed for educating traditional healing providers and patients”.
Fear of Mastectomy and Stigma
Research among Ghanaian women has documented a profound fear of mastectomy—the surgical removal of the breast. A study of patients with confirmed breast cancer found that fear of diminished sexuality and femininity was a dominant theme. One woman stated: “A woman’s glory is her breast, so what is your use if one of your breasts is not there? I will rather die with my two breasts than live with one.” Another recounted that her husband wanted a divorce because he said she had been “maimed”.
This fear, combined with limited access to reconstructive surgery, creates a powerful disincentive to seek timely care.
Limited Knowledge and Misconceptions
While awareness of breast cancer is high, knowledge about symptoms and screening is shallow. A study of Islamic women in Kumasi found that despite perceived high benefits of screening, actual screening practices were poor due to fear of unmet cultural preferences at screening centers and poor knowledge about breast cancer.
Misconceptions persist. One participant believed that “when you put money in your brassiere, you can develop it.” Another thought that “when you do the surgery you will die… so when I was at the surgical ward, they even booked me for that surgery and I run away”.
Educational and Socioeconomic Disparities
A population-based case-control study of 1,184 women with breast malignancies in Accra and Kumasi identified strong predictors of larger tumor masses at diagnosis. Limited education was a significant factor: women with less than junior secondary schooling who delayed seeking care for six months or longer were at nearly four times the risk of more educated women who sought prompt assistance.
The study concluded that “additional communication, particularly among less educated women, could promote earlier breast cancer diagnoses”.
The Treatment Completion Crisis
Even when women are diagnosed, many do not complete treatment.
At KATH, only 18.5% of patients with confirmed breast cancer completed the recommended multimodal treatment without abandonment. This falls dramatically short of the GBCI benchmark of over 80%.
The reasons are financial and structural. While the National Health Insurance Scheme (NHIS) covers adjuvant treatments including chemotherapy and hormone therapy, the reported average availability of cancer medicines in Ghanaian public hospitals is just 14%, far below the WHO target of 80%. When NHIS-approved drugs run out of stock, patients must pay out-of-pocket.
The result is predictable. Among patients initiating treatment at KATH, 93.3% of those who died had not completed treatment, while 72.3% of those alive had completed it.
The Referral Gap
A prospective study of 243 women presenting at district and regional hospitals in the Volta and Oti Regions found that among 102 women with malignant biopsies, 61% were stage III or IV. Only 64% initiated treatment, with a median time from first visit to treatment initiation of 76 days. Thirty-seven women whose biopsies were malignant did not initiate treatment at all, due to participant-related (51%) and health system-related (32%) factors.
The study noted that “large gaps in biopsy uptake and treatment access” exist at lower levels of the health system, even when pathology turnaround times are excellent.
What This Means
Ghana has demonstrated that it can diagnose breast cancer quickly. The diagnostic infrastructure at KATH and other tertiary centers functions. But the country has not yet solved the two challenges that matter most: getting women to present early, and ensuring they complete treatment once diagnosed.
The GBCI framework identifies three pillars: early detection, timely diagnosis, and comprehensive management. Ghana meets the target for the second pillar. It falls considerably short on the first and third.
The path forward requires addressing the cultural, educational, and financial barriers that keep women from seeking care—and the systemic gaps that prevent them from completing it. Until then, late detection will remain Ghana’s most persistent breast cancer challenge.
Quick Facts
| Topic | Details |
|---|---|
| Early-Stage Diagnosis (KATH) | 10.3% (target: 60%) |
| Late-Stage Diagnosis | 50% stage III, 39.3% stage IV |
| Pooled 5-Year Survival | 46.5% |
| Pooled Median Survival | 4.4 years |
| Mean Age at Diagnosis | 47.3 years |
| Traditional Medicine Use | 4.14x higher odds of late-stage |
| Treatment Completion (KATH) | 18.5% |
| Cancer Medicine Availability | 14% in public hospitals |
| Annual Deaths (Estimate) | ~2,000 |
Frequently Asked Questions
1. Why is late detection a major concern for breast cancer in Ghana?
Most Ghanaian women are diagnosed at advanced stages. At KATH, only 10.3% are diagnosed at stage I or II, while 50% are stage III and 39.3% stage IV. This dramatically reduces survival rates.
2. What is the most significant factor associated with late-stage diagnosis in Ghana?
A 2025 study found that using traditional medicine before seeking care at a cancer hospital was the only significant patient factor associated with late-stage diagnosis. Patients who used traditional medicine had 4.14 times higher odds of late-stage presentation.
3. Why do Ghanaian women fear mastectomy?
Research shows fear of diminished sexuality and femininity is a dominant theme. One woman said: “A woman’s glory is her breast, so what is your use if one of your breasts is not there?” Combined with limited access to reconstructive surgery, this creates a powerful disincentive to seek timely care.
4. What is the 5-year survival rate for breast cancer in Ghana?
A 2026 meta-analysis of 2,114 patients found a pooled 5-year survival rate of 46.5% and a median overall survival of 4.4 years.
5. Why do patients abandon breast cancer treatment in Ghana?
The main reasons are cost and access. Cancer medicines are available in only 14% of public hospitals, forcing patients to pay out-of-pocket. Up to 86% of patients at KATH cannot complete treatment without interruption.
6. Does the NHIS cover breast cancer treatment?
The NHIS covers chemotherapy and radiotherapy. However, when NHIS-approved drugs run out of stock, patients must pay out-of-pocket. Rehabilitative care is not covered.
7. How does education affect breast cancer diagnosis in Ghana?
A study of 1,184 women found that limited education was a significant predictor of larger tumor masses. Women with less than junior secondary schooling who delayed care for six months or longer were at nearly four times the risk of more educated women.
8. What is the GBCI target for early detection?
The Global Breast Cancer Initiative targets diagnosing at least 60% of cases at an early stage. Ghana is currently at 10.3%
Source: Accra Street Journal
Last Updated on October 4, 2026 by Samuel Kwame Boadu
Disclaimer: Some content on Accra Street Journal may be aggregated, summarized, or edited from third-party sources for informational purposes. Images and media are used under fair use or royalty-free licenses. Accra Street Journal is a subsidiary of SamBoad Publishing Hub under SamBoad Business Group Ltd, registered in Ghana since 2014.
For concerns or inquiries, please visit our Privacy Policy or Contact Page.
Samuel Kwame Boadu is a Ghanaian media entrepreneur and storyteller with a passion for amplifying urban voices and uncovering everyday truths. He is the Editor-in-Chief and Founder of Accra Street Journal, a dynamic digital platform dedicated to capturing the pulse of Ghana’s capital—its people, culture, challenges, business, sports and innovations.
